Eberlein, Tempero, Hoppe, Kolodziej, Burns win NCCN awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Comprehensive Cancer Network announced the recipients of a series of awards honoring individuals whose contributions fueled progress in improving and facilitating quality, effective, efficient, and accessible cancer care over the past year:

  • Timothy Eberlein,
    Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

    • Outgoing board of directors chair Eberlein was presented with a Board of Producers Award.

  • Margaret Tempero,
    UCSF Helen Diller Family Comprehensive Cancer Center

    • A Board of Producers Award went to Tempero in honor of her long history of contributions to NCCN, which include chairing the NCCN Clinical Practice Guidelines in Oncology Panel for Pancreatic Cancer

  • Richard Hoppe,
    Stanford Cancer Institute

    • Hoppe received the Rodger Winn Award for expert judgment and commitment to excellence in service of the NCCN Guidelines. As the founding chair of the NCCN Guidelines Panel for Hodgkin Lymphoma, the award is in memory of the first leader of the NCCN Guidelines program.

  • Michael Kolodziej,
    ADVI

    • Kolodziej was awarded as a Partner in Cancer Care in appreciation for his efforts to engage policymakers, employers, payers, and others to improve the accessibility of high-quality cancer care.

  • Jennifer Burns,
    NCCN

    • Burns is a Guidelines Coordinator with NCCN’s Clinical Information Operations team. She was named the Pat Daulerio Employee of the Year Award recipient by her peers at NCCN. The award honors the memory of a longtime employee in NCCN’s meetings department.

Table of Contents

YOU MAY BE INTERESTED IN

For nearly 25 years, business executive Lou Weisbach and urologist Richard J. Boxer have argued that finding the money to finance the cures for devastating diseases is not as difficult as it appears. To start finding the cures, the U.S. Department of the Treasury needs to issue some bonds—$750 billion worth. Next, you hire CEOs—one...

There is general agreement that the United States spends too much on health care, especially on pharmaceuticals.  But what we spend on drugs is not simply a function of price. If eggs double in price, people can simply cut the number of eggs they eat in half.  Simply stated, cost is the product of (price per unit times the number of units purchased). 
What did President Richard M. Nixon and Senator Edward M. Kennedy have in common? They each played a pivotal role in the passage of the National Cancer Act signed by Nixon on Dec. 23, 1971. The NCA established the National Cancer Program authorizing the initial investment in the NCI-designated Cancer Centers Program. 
When I first proposed targeting PCNA (proliferating cell nuclear antigen) as a therapeutic approach, the response I got was: “No one will ever make a drug against PCNA. It’s undruggable.” The protein lacks enzymatic activity, has a disordered region, and binds to over 200 other proteins within the cell. From a traditional drug development perspective, these characteristics made PCNA an impossible target.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login